Cantor Fitzgerald, L. P. I Mab Transaction History
Cantor Fitzgerald, L. P.
- $2.48 Billion
- Q4 2024
A detailed history of Cantor Fitzgerald, L. P. transactions in I Mab stock. As of the latest transaction made, Cantor Fitzgerald, L. P. holds 140,100 shares of IMAB stock, worth $135,897. This represents 0.0% of its overall portfolio holdings.
Number of Shares
140,100Holding current value
$135,897% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding IMAB
# of Institutions
35Shares Held
16.5MCall Options Held
0Put Options Held
14.5K-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$5.8 Million0.19% of portfolio
-
Decheng Capital Management Iii (Cayman), LLC4.17MShares$4.04 Million3.04% of portfolio
-
Morgan Stanley New York, NY3.54MShares$3.44 Million0.0% of portfolio
-
Sg Americas Securities, LLC476KShares$461,5860.0% of portfolio
-
David A. Siegel Two Sigma Advisers, LP | New York, Ny431KShares$417,8760.0% of portfolio
About I-Mab
- Ticker IMAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 83,098,800
- Market Cap $80.6M
- Description
- I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics to treat cancer and autoimmune disorders. It is developing Felzartamab, a CD38 antibody that is in Phase 1b/2a for patients with membranous nephropathy; Eftansomatropin alfa, a long-acting human growth hormone, which has completed Phase 3 clinica...